RV4421B

· Pierre Fabre Dermo Cosmetique

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RV4421B, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks [NA]

See pricing